From: The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
Patients (n) | 101 |
Age median (range) | 69 years (43–87) |
PSA median (range) | 11.113 ng/ml (0.970–178.200) |
IR(n) | 49 |
HR(n) | 52 |
GS | |
GS 6 | 4 |
GS 7a | 30 |
GS 7b | 37 |
GS 8 | 9 |
GS 9 | 21 |
Clinical T-stage | |
T1c | 41 |
T2a | 9 |
T2b | 7 |
T2c | 39 |
T3a | 2 |
T3b | 3 |